Jul 31, 2026 07:47AM
Jul 30, 2026 08:00AM
Jul 29, 2026 03:00AM
Jul 29, 2026 03:00AM
Jul 29, 2026 03:00AM
Jul 23, 2026 04:00PM
Jul 23, 2026 04:00PM Genmab and AbbVie Provide Clarification on Phase 3 EPCORE® DLBCL-1 Trial Evaluating Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Jul 14, 2026 08:05AM
Jul 14, 2026 08:05AM
Jul 1, 2026 09:05AM
Jun 29, 2026 04:20PM
Jun 29, 2026 04:15PM
Jun 29, 2026 04:15PM
Jun 29, 2026 03:10AM AbbVie's Rinvoq gets positive EU panel opinion for hair loss
Jun 29, 2026 03:10AM
Jun 29, 2026 03:00AM
Jun 29, 2026 03:00AM
Jun 26, 2026 04:52PM
Jun 26, 2026 04:50PM
Jun 25, 2026 09:04AM
Jun 23, 2026 04:09AM EU approves AbbVie's Skyrizi for children with plaque psoriasis
Jun 23, 2026 03:00AM
Jun 16, 2026 08:15AM
Jun 16, 2026 08:01AM
Jun 16, 2026 08:00AM
Jun 8, 2026 08:01AM
Jun 8, 2026 08:00AM
May 27, 2026 06:18PM FDA approves AbbVie's DECNUPAZ for rare blood cancer treatment
May 27, 2026 06:18PM
May 27, 2026 03:38PM
May 13, 2026 08:30AM
May 13, 2026 08:30AM
May 5, 2026 08:05AM
May 5, 2026 08:05AM
Apr 29, 2026 07:47AM AbbVie Reports First-Quarter 2026 Financial Results
Apr 28, 2026 08:00AM
Apr 27, 2026 08:05AM
Apr 27, 2026 08:05AM
Apr 23, 2026 04:35PM
Apr 23, 2026 04:06PM
Apr 23, 2026 04:05PM
Apr 12, 2026 07:15AM AbbVie presents phase 2 ovarian cancer trial data at SGO meeting
Apr 12, 2026 07:15AM
Mar 31, 2026 08:05AM
Mar 27, 2026 10:00AM
Mar 12, 2026 06:55AM
Mar 2, 2026 08:30AM
Mar 2, 2026 08:30AM
Feb 20, 2026 05:29AM FDA approves AbbVie's VENCLEXTA-acalabrutinib combo for untreated CLL
Feb 20, 2026 02:00AM

327,059 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All